Abstract:Extracellular matrix-degrading matrix metalloproteinase-1 (MMP-1) is one of the interstitial collagenases likely to be involved in tumor invasion and metastasis. MMP-1 may also contribute to tumor initiation and development by altering the cellular microenvironment that facilitates tumor formation. Recent studies have found that overexpression of MMP-1 is associated with the initial stages of cancer development in addition to promoting cellular invasion; however, preexisting oncogenic mutations or chemical carcinogens are required to initiate tumorigenesis as well. There is a single nucleotide polymorphism located in the promoter region of MMP-1 that partially regulates gene expression. The 2G/2G genotype enhances transcriptional activity and may be associated with an increased lung cancer risk. Using a case-control study, we tested the hypotheses that (a) individuals with the 2G/2G genotype may be at an increased risk for lung cancer; and (b) the risk should be greatly elevated in smoking individuals. PCR-RFLP was used to determine the MMP-1 genotypes in 456 lung-cancer cases and 451 frequency-matched controls of Caucasian ethnicity. Overall, there was a significant association between the 2G/2G genotype and lung cancer risk [odds ratio (OR), 1.76; 95% confidence interval (CI), 1.29–2.39]. In current smokers, the lung cancer risk associated with the 2G/2G genotype was significantly elevated (OR, 3 .16; 95% CI, 1.87–5.35). However, this association was less evident in former smokers (OR, 1.23; 95% CI, 0.81–1.87) and absent in never smokers (OR, 1.09; 95% CI, 0.31–3.91). Similarly, this risk was more evident in heavy smokers (OR, 2.55; 95% CI, 1.61–4.03) than in light smokers (OR, 1.40; 95% CI, 0.84–2.32). Interestingly, men were observed to have a 2.15-fold increased lung cancer risk (OR, 2.15; 95% CI, 1.42–3.26) compared with women (OR, 1.34; 95% CI, 0.84–2.15). Furthermore, subjects with 2G/2G genotype developed lung cancer earlier (60.94 0.64 years old) than patients with 1G/1G and 1G/2G genotypes (62.91 0.59 years old; P 0.024). Our data demonstrate that the 2G/2G genotype enhances lung cancer susceptibility especially in current smokers. To our knowledge, these results report the first molecular epidemiological evidence of the MMP-1 promoter polymorphism associated with the development of lung cancer in the presence of continuing carcinogenic exposure.

Association Between Asbestos Exposure, Cigarette Smoking, Myeloperoxidase (MPO) Genotypes, and Lung Cancer Risk.

A Myeloperoxidase Polymorphism Associated with Reduced Risk of Lung Cancer

Genetic Variants of Myeloperoxidase and Lung Cancer Risk

Myeloperoxidase G-463A Polymorphism and Lung Cancer: A HuGE Genetic Susceptibility to Environmental Carcinogens Pooled Analysis

Myeloperoxidase G463A Polymorphism and Lung Cancer Risk in Asians: a Pooled Analysis

Combined Effects of Cigarette Smoking, Gene Polymorphisms and Methylations of Tumor Suppressor Genes on Non Small Cell Lung Cancer: a Hospital-Based Case-Control Study in China

Association of miR-605 and miR-149 genetic polymorphisms with related risk factors of lung cancer susceptibility]

Association of the MspI Polymorphism of Cytochrome P4501A1 Gene and Smoking to the Susceptibility to Coronary Artery Disease

Effects Of Methylation Of P16 Gene, Polymorphism Of Gstm1 Gene And Environmental Factors On Susceptibility To Lung Cancer

Myeloperoxidase promoter region polymorphism and lung cancer risk.

Association of the 463G-A myeloperoxidase gene polymorphism with gastric cancer risk.

Associations Between Cytochrome P4502e1 Genotype, Mutagen Sensitivity, Cigarette Smoking and Susceptibility to Lung Cancer

Myeloperoxidase Polymorphism and Coronary Artery Disease Risk: A Meta-Analysis.

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility 1

A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter Enhances Lung Cancer Susceptibility.

Microsomal Epoxide Hydrolase Polymorphisms and Lung Cancer Risk in Non‐hispanic Whites

Association of myeloperoxidase polymorphism (G463A) with cervix cancer

Correlation Between A Single Nucleotide Polymorphism In The Matrix Metalloproteinase-2 Promoter And Risk Of Lung Cancer

The Association of Microsomal Epoxide Hydrolase Polymorphisms and Lung Cancer Risk in African-Americans and Mexican-Americans

Associations Between Polymorphisms of the XPC Gene and Lung Cancer Susceptibility: a Meta-Analysis.

Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis.